Upadacitinib, also known as ABT-494, is a drug that is classified as a Janus kinase (JAK) inhibitor. The medication is used to treat various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and atopic dermatitis. It was developed by AbbVie Inc. and approved by the FDA in 2019.
Chemical Name:
The chemical name of Upadacitinib is (Z)-2-(1-(1H-pyrazolo[3,4-b]pyridin-4-yl)ethoxy)-N-(2-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-2-methylpropyl)acetamide.
Molecular Formula:
The molecular formula of Upadacitinib is C22H23F2N5O3.
Formula Weight:
The formula weight of Upadacitinib is 445.45 g/mol.
CAS No:
The CAS No for Upadacitinib is 1310726-60-3.
Top ten Keywords from Google and Synonyms:
Health benefits of this Product:
Upadacitinib has been found to be effective in treating rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and atopic dermatitis. These conditions are all autoimmune diseases, which occur when the body's immune system mistakenly attacks healthy cells and tissues.
Potential Effects:
Upadacitinib is a potent inhibitor of JAK enzymes, which are involved in the process of inflammation in the body. By inhibiting these enzymes, Upadacitinib can help reduce inflammation and pain in patients with autoimmune diseases. This medication has also been found to help improve joint function and reduce the progression of joint damage in patients with rheumatoid arthritis.
Product Mechanism:
Upadacitinib works by blocking the activity of JAK enzymes, which are involved in the inflammatory process in the body. Specifically, it inhibits JAK1, which is involved in the production of cytokines, proteins involved in the regulation of inflammation. By blocking JAK1, Upadacitinib can help reduce inflammation and alleviate symptoms of autoimmune diseases.
Safety:
Upadacitinib has shown to be generally safe in clinical trials, with no major safety concerns reported. However, long-term safety and potential side effects are still being studied.
Side Effects:
Common side effects of Upadacitinib include headaches, upper respiratory tract infections, and gastrointestinal issues such as nausea and diarrhea. More serious side effects, although rare, may include infections and an increased risk of blood clots.
Dosing Information:
Upadacitinib is available in tablet form and is typically taken once a day. The dosage may vary depending on the patient's condition, age, and other factors. It is important to follow the prescribed dosage and instructions provided by your healthcare provider.
Conclusion:
Upadacitinib is a promising medication in the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and atopic dermatitis. It works by inhibiting JAK enzymes, which are involved in the inflammatory process in the body. While generally safe, potential side effects and long-term safety are still being studied. It is important to consult with your healthcare provider before starting Upadacitinib to determine if it is right for you
